Photo from SOLID Therapeutics/LinkedIn
Oct 8, 2024, 13:41
SOLID Therapeutics receives Innobooster grant
SOLID Therapeutics shared a post on LinkedIn:
”Funding News!
We’re thrilled to announce that Innovation Fund Denmark has awarded us an Innobooster grant!
This crucial support will accelerate the development of our first in class HCAR1 antagonists, bringing us one step closer to offering new hope to patients battling solid tumors.
We are very grateful to Innovation Fund Denmark for their continued support in our mission.”
Hagop Youssoufian, Founder and Principal of Youssoufian Consulting and shared a post by SOLID Therapeutics, on LinkedIn, adding:
”Enthusiastic congratulations to the SOLID team. I couldn’t be more proud: What a great culture of innovation and collaboration!”
Source: SOLID Therapeutics/LinkedIn and Hagop Youssoufian/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 12:57
Nov 21, 2024, 12:54
Nov 21, 2024, 12:49
Nov 21, 2024, 12:36
Nov 21, 2024, 09:55
Nov 21, 2024, 09:28
Nov 21, 2024, 09:23
Nov 21, 2024, 09:04